(APXJ) Amundi Index MSCI Pacific - Ratings and Ratios
ESG, Equity, Pacific, Ex-Japan, Developed
Description: APXJ Amundi Index MSCI Pacific
The Amundi Index MSCI Pacific Ex Japan SRI PAB - UCITS ETF DR - EUR (D) is an exchange-traded fund (ETF) that tracks the Morningstar Developed APAC ex-Japan TME NR USD index, providing investors with exposure to Pacific ex-Japan equity markets with a focus on sustainable and responsible investing (SRI) and a Paris-Aligned Benchmark (PAB) approach.
By tracking the Morningstar index, this ETF offers a diversified portfolio of stocks from developed markets in the Asia-Pacific region, excluding Japan. The funds SRI and PAB focus means it is designed to be aligned with the goals of the Paris Agreement, aiming to reduce carbon emissions and promote sustainable business practices among its constituent companies.
From a technical analysis perspective, the ETFs price action indicates a relatively stable trend, with its 20-day simple moving average (SMA20) at 9.41 and 50-day simple moving average (SMA50) at 9.23. The current price of 9.33 is slightly below the SMA20, suggesting a potential short-term correction. However, the 200-day simple moving average (SMA200) at 9.35 indicates a longer-term uptrend. The average true range (ATR) of 0.08 (0.84%) suggests moderate volatility.
With assets under management (AUM) of 500.28 million EUR, the fund has a significant presence in the market, which can contribute to liquidity and potentially lower trading costs for investors. The funds size and the underlying indexs diversification across the Pacific ex-Japan region can make it an attractive option for investors seeking broad exposure to this market with a sustainability focus.
Forecasting future performance based on the available technical and fundamental data, a potential short-term correction could be anticipated due to the ETFs price being below its SMA20. However, the longer-term uptrend indicated by the SMA200 and the funds underlying index composition suggest potential for growth. Investors should monitor the ETFs price action relative to its moving averages and ATR for signs of trend continuation or reversal. Additionally, the funds AUM and the overall trend in sustainable investing could support its long-term prospects.
Additional Sources for APXJ ETF
APXJ ETF Overview
Market Cap in USD | 59m |
Category | Pacific ex-Japan Equity |
IPO / Inception | 2021-12-07 |
APXJ ETF Ratings
Growth Rating | 3.76 |
Fundamental | - |
Dividend Rating | 42.6 |
Rel. Strength | -19.9 |
Analysts | - |
Fair Price Momentum | 8.67 EUR |
Fair Price DCF | - |
APXJ Dividends
Dividend Yield 12m | 2.99% |
Yield on Cost 5y | 3.03% |
Annual Growth 5y | 1.22% |
Payout Consistency | 96.5% |
Payout Ratio | % |
APXJ Growth Ratios
Growth Correlation 3m | 71.8% |
Growth Correlation 12m | -2.2% |
Growth Correlation 5y | 17.2% |
CAGR 5y | 0.17% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | 0.08 |
Alpha | -4.39 |
Beta | 0.575 |
Volatility | 11.88% |
Current Volume | 10.8k |
Average Volume 20d | 7.4k |
Stop Loss | 9 (-3.3%) |
As of July 17, 2025, the stock is trading at EUR 9.31 with a total of 10,782 shares traded.
Over the past week, the price has changed by -0.12%, over one month by -1.55%, over three months by +7.08% and over the past year by +3.28%.
Neither. Based on ValueRay´s Analyses, Amundi Index MSCI Pacific is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 3.76 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of APXJ is around 8.67 EUR . This means that APXJ is currently overvalued and has a potential downside of -6.87%.
Amundi Index MSCI Pacific has no consensus analysts rating.
According to our own proprietary Forecast Model, APXJ Amundi Index MSCI Pacific will be worth about 9.7 in July 2026. The stock is currently trading at 9.31. This means that the stock has a potential upside of +3.97%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 9.7 | 4% |